Biomaterials Research (생체재료학회지)

Korean Society for Biomaterials (한국생체재료학회)
권호 표지
DOI QR코드

DOI QR Code

The market trend analysis and prospects of scaffolds for stem cells

  • Received : 2014.07.16
  • Accepted : 2014.08.18
  • Published : 2014.12.01
⟨ Previous Next ⟩

Abstract

Background: Scaffolds are one of the three most important elements constituting the basic concept of regenerative medicine, and are included in the core technology of regenerative medicine along with stem cells and tissue engineering. Stem cells are very important technology because they are directly responsible for the regenerative treatment of the disease and the damaged tissue, but with regards to the technology and the products that use stem cells exclusively, there is a technical limitation of limited survival rate and the engraftment rate of the transplanted cell, and rather than recovering the damaged tissue fundamentally, there is a limit that the concept is more of just another medicine treatment using cells. A scaffold is a natural or synthetic biocompatible material transplanted into a human body to be used as the exclusive treatment or as an assisted method of another treatment of a disease and for the recovery of damaged tissue. Therefore, according to the characteristics of the tissue to be applied, scaffolds must have the characteristics such as the excellent biocompatibility, biodegradability, minimum immunity and inflammation, proper mechanical strength and interaction between the material and the cells. Results: The world stem cell market was approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021. Meanwhile, the world scaffold element technology market was approximately 4.57 million dollars in 2013, and by increasing 13.4% annually, it is estimated to expand to 10.63 million dollars by 2020. The Korean scaffold element technology market was about 22 million dollars in 2013, and with a steady growth of approximately 13.4% every year, it is prospected to be about 52 million dollars by 2020. Conclusions: In comparison to the medical material and medicine sales growth rate, the future scaffold element technology market is judged to be higher in growth possibility.

Keywords

References

  1. Visiongain: Stem Cell Technologies World Market Outlook 2011-2021. ; 2010.
  2. Mano JF, Sousa RA, Boesel LF, Neves NM, Reis RL: Bioinert, biodegradable and injectable polymeric matrix composites for hard tissue replacement: state of the art and recent developments. Composites Sci Technol 2004, 64(6):789-817. https://doi.org/10.1016/j.compscitech.2003.09.001
  3. Shin H, Jo S, Mikos AG: Biomimetic materials for tissue engineering. Biomaterials 2003, 24(24):4353-4364. https://doi.org/10.1016/S0142-9612(03)00339-9
  4. Atala A: Engineering organs. Curr Opin Biotechnol 2009, 20(5):575-592. https://doi.org/10.1016/j.copbio.2009.10.003
  5. Atala A: Regenerative medicine and tissue engineering in urology. Urol Clin North Am 2009, 36(2):199-209. https://doi.org/10.1016/j.ucl.2009.02.009
  6. Atala A: Tissue engineering of reproductive tissues and organs. Fertil Steril 2012, 98(1):21-29. https://doi.org/10.1016/j.fertnstert.2012.05.038
  7. Atala A, Kasper FK, Mikos AG: Engineering complex tissues. Sci Transl Med 2012, 4(160):Article ID: 160rv12160rv12.
  8. Rim N, Lee Y, Kim S, Shin H: Current status and prospect of biomaterials as tissue substitutes in regenerative medicine. Korean Ind Chem News 2010, 13(6):2-17.
  9. Chen F, Yoo JJ, Atala A: A cellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. Urology 1999, 54(3):407-410. https://doi.org/10.1016/S0090-4295(99)00179-X
  10. Chun S, Lim GJ, Kwon TG, Kwak EK, Kim BW, Atala A, Yoo JJ: Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 2007, 28(29):4251-4256. https://doi.org/10.1016/j.biomaterials.2007.05.020
  11. Yoo JJ, Meng J, Oberpenning F, Atala A: Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 1998, 51(2):221-225. https://doi.org/10.1016/S0090-4295(97)00644-4
  12. Kim B, Atala A, Yoo JJ: A collagen matrix derived from bladder can be used to engineer smooth muscle tissue. World J Urol 2008, 26(4):307-314. https://doi.org/10.1007/s00345-008-0300-1
  13. Korea Food and Drug Administration: A Study on Evaluation Criteria for Quality of Mesenchymal Stem Cell based Tissue Engineering Products: Searching for Molecular Biological Method. ; 2007.
  14. Lee H, Khang G, Kim M, Rhee JM, Lee I, Min B: Scaffold for tissue engineering. Tissue Eng Regen Med 2006, 3(4):1738-2696.
  15. LG Economic Research Institute: StemCell: Gap between Possibility and Reality. 2013.
  16. Ehwa Womans University: Research on the Evaluation Method for Bioactive Medical Devices. ; 2009.
  17. Choi B, Park S: Current status and future perspectives of stem cells and regenerative medicine. Hanyang Med Rev 2012, 32(3):127-133. https://doi.org/10.7599/hmr.2012.32.3.127
  18. TriMark Publication: Regenerative Medicine Markets. ; 2013.
  19. Lee CH, Singla A, Lee Y: Biomedical applications of collagen. Int J Pharm 2001, 221(1):1-22. https://doi.org/10.1016/S0378-5173(01)00691-3
  20. Job L, van Susante C, Jeroen P, Pieter B, van Kuppevelt TH, van Beuningen H, van der Kraan PM, Veerkamp JH, van den Berg WB, René P, Veth H: Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro Biomaterials. Biomaterials 2001, 22(17):2359-2369. https://doi.org/10.1016/S0142-9612(00)00423-3
  21. Murray MM, Rice K, Wright RJ, Spector M: The effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen-GAG scaffold. J Orthop Res 2003, 21(2):238-244. https://doi.org/10.1016/S0736-0266(02)00142-0
  22. Lee S, Yoo JJ, Atala A: Recent applications of polymeric biomaterials and stem cells in tissue engineering and regenerative medicine. Polymer 2014, 38(2):113-128.
  23. Shinhan Investment Corp: Sector Report: Stem-Cell Theraphy Products. 2011.
  24. 10 Growth Strategies for Stem Cell Industry. Korea Health Industry Development Institute; 2005.
  25. Investment Strategies for Stem Cell Technology. Korean Ministry of Education, Korean Ministry of Health and Welfare, Korean Ministry of Knowledge Economy, Korean Ministry of Agriculture, Food and Rural Affairs. 2012.
  26. HTStec: 3D Cell Culture Trends 2011. 2011.
  27. Korea Health Industry Development Institute: Medical Resource Statistics Handbook. 2012.

Cited by

  1. Graphene and graphene-based nanocomposites: biomedical applications and biosafety vol.4, pp.48, 2014, https://doi.org/10.1039/c6tb02086k
  2. Fabrication of 3D structures from graphene-based biocomposites vol.5, pp.19, 2014, https://doi.org/10.1039/c6tb02442d
  3. Fabrication of graphene-biomacromolecule hybrid materials for tissue engineering application vol.8, pp.30, 2014, https://doi.org/10.1039/c7py00935f
  4. Graphene oxide-modified electrospun polyvinyl alcohol nanofibrous scaffolds with potential as skin wound dressings vol.7, pp.46, 2014, https://doi.org/10.1039/c7ra03997b
  5. Genipin-crosslinked adipose stem cell derived extracellular matrix-nano graphene oxide composite sponge for skin tissue engineering vol.6, pp.6, 2014, https://doi.org/10.1039/c7tb02480k
  6. Modulation of dielectric and viscoelastic features of silicone rubber (SR) by nano-hydroxylapatite (n-HA) embedding vol.42, pp.8, 2014, https://doi.org/10.1039/c8nj00262b
  7. Review—Biosensing and Biomedical Applications of Graphene: A Review of Current Progress and Future Prospect vol.166, pp.6, 2014, https://doi.org/10.1149/2.1231906jes
  8. Mechanical Properties of Aliphatic Polyester‐Based Structurally Engineered Composite Patches vol.384, pp.1, 2019, https://doi.org/10.1002/masy.201800153
  9. Herbally Painted Biofunctional Scaffolds with Improved Osteoinductivity for Bone Tissue Engineering vol.41, pp.None, 2014, https://doi.org/10.4028/www.scientific.net/jbbbe.41.49
  10. Graphene oxide incorporated polycaprolactone/chitosan/collagen electrospun scaffold: Enhanced osteogenic properties for bone tissue engineering vol.43, pp.10, 2014, https://doi.org/10.1111/aor.13474
  11. Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia vol.23, pp.1, 2019, https://doi.org/10.1186/s40824-019-0164-z
  12. Preparation and characterization of antibacterial dopamine-functionalized reduced graphene oxide/PLLA composite nanofibers vol.10, pp.32, 2014, https://doi.org/10.1039/d0ra03224g
  13. Reduced graphene oxide coating enhances osteogenic differentiation of human mesenchymal stem cells on Ti surfaces vol.25, pp.1, 2021, https://doi.org/10.1186/s40824-021-00205-x